ID   486P
AC   CVCL_7940
SY   486-P
DR   ATCC; HTB-7
DR   IARC_TP53; 21035
DR   Wikidata; Q54603306
RX   DOI=10.1016/B978-0-12-043050-5.50049-4;
RX   PubMed=66978;
RX   PubMed=571047;
RX   PubMed=748774;
RX   PubMed=944089;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=29732388;
CC   Population: Caucasian.
CC   Doubling time: 35 hours (PubMed=66978; PubMed=748774).
CC   Discontinued: ATCC; HTB-7; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
RX   DOI=10.1016/B978-0-12-043050-5.50049-4;
RA   Elliott A.Y., Bronson D.L., Cervenka J., Cleveland P.H., Fraley E.E.;
RT   "Establishment and characterization of epithelial cell cultures from
RT   tumors of the human urinary tract.";
RL   (In) Cell culture and the application; Acton R. (eds.); pp.711-728; Academic Press; New York (1977).
//
RX   PubMed=66978;
RA   Elliott A.Y., Bronson D.L., Cervenka J., Stein N., Fraley E.E.;
RT   "Properties of cell lines established from transitional cell cancers
RT   of the human urinary tract.";
RL   Cancer Res. 37:1279-1289(1977).
//
RX   PubMed=571047;
RA   Fogh J.;
RT   "Cultivation, characterization, and identification of human tumor
RT   cells with emphasis on kidney, testis, and bladder tumors.";
RL   Natl. Cancer Inst. Monogr. 49:5-9(1978).
//
RX   PubMed=748774;
RA   Elliott A.Y., Bronson D.L., Fraley E.E.;
RT   "Transitional cell cancer: establishment and characterization of cell
RT   lines.";
RL   Natl. Cancer Inst. Monogr. 49:23-24(1978).
//
RX   PubMed=944089;
RA   Elliott A.Y., Bronson D.L., Stein N., Fraley E.E.;
RT   "In vitro cultivation of epithelial cells derived from tumors of the
RT   human urinary tract.";
RL   Cancer Res. 36:365-369(1976).
//
RX   PubMed=3518877; DOI=10.3109/07357908609038260;
RA   Fogh J.;
RT   "Human tumor lines for cancer research.";
RL   Cancer Invest. 4:157-184(1986).
//
RX   PubMed=6244232;
RA   Williams R.D.;
RT   "Human urologic cancer cell lines.";
RL   Invest. Urol. 17:359-363(1980).
//
RX   PubMed=6582512; DOI=10.1073/pnas.81.2.568;
RA   Mattes M.J., Cordon-Cardo C., Lewis J.L. Jr., Old L.J., Lloyd K.O.;
RT   "Cell surface antigens of human ovarian and endometrial carcinoma
RT   defined by mouse monoclonal antibodies.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:568-572(1984).
//
RX   PubMed=6935474; DOI=10.1093/jnci/66.2.239;
RA   Wright W.C., Daniels W.P., Fogh J.;
RT   "Distinction of seventy-one cultured human tumor cell lines by
RT   polymorphic enzyme analysis.";
RL   J. Natl. Cancer Inst. 66:239-247(1981).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//